Impact of neoadjuvant chemotherapy on survival in breast cancer patients in daily practice: a population-based study.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  European Journal of Cancer Care

• Publication date

  2013-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/ecc.12069PMID 23647444
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neoadjuvant chemotherapy in breast cancer: review of literature.

  2013cited by this paper
• Global cancer statistics

  2011cited by this paper
• TNM Classification of Malignant Tumours, 7th Edition

  2009cited by this paper
• Population-based study of breast cancer survival in Cote d'Or (France): prognostic factors and relative survival.

  2008cited by this paper
• Global Cancer Statistics, 2002

  2005cited by this paper
• RESPONSE: Re: Neoadjuvant Versus Adjuvant Systemic Treatment in Breast Cancer: A Meta-Analysis

  2005influential reference
• Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis.

  2005influential reference
• Primary chemotherapy for breast cancer: the evidence and the future.

  2004cited by this paper
• Regression models for relative survival

  2004influential reference
• The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27.

  2003cited by this paper
• Revision of the American Joint Committee on Cancer staging system for breast cancer.

  2002cited by this paper
• Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel.

  2002cited by this paper
• Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902.

  2001cited by this paper
• Short and long‐term effects on survival in breast cancer patients treated by primary chemotherapy: an updated analysis of a randomized trial

  1999cited by this paper
• Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up. Institut Bergonié Bordeaux Groupe Sein (IBBGS).

  1999influential reference
• Tamoxifen for early breast cancer: An overview of the randomised trials

  1999cited by this paper
• Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

  1998cited by this paper
• Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.

  1998cited by this paper
• Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute.

  1998cited by this paper
• Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma.

  1998cited by this paper
• Indications for neoadjuvant chemotherapy for breast cancer.

  1998cited by this paper
• Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18.

  1997influential reference
• Primary chemotherapy in operable breast cancer.

  1996cited by this paper
• Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer.

  1995cited by this paper
• Review of survival analyses published in cancer journals.

  1995cited by this paper
• Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of a randomised trial: S6.

  1994cited by this paper
• Conservative treatment feasibility with induction chemotherapy, surgery, and radiotherapy for patients with breast carcinoma larger than 3 cm

  1994cited by this paper
• Feasibility of breast‐conservation surgery after induction chemotherapy for locally advanced breast carcinoma

  1992cited by this paper
• Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm. Results of a randomized trial in a single centre.

  1991cited by this paper
• Neoadjuvant chemotherapy in operable breast cancer.

  1991cited by this paper
• Neoadjuvant chemotherapy in operabla breast cancer

  1991cited by this paper
• Comprehensive management of locally advanced breast cancer

  1990cited by this paper
• Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy

  1988cited by this paper
• Multimodal treatment of locoregionally advanced breast cancer

  1983cited by this paper
• The value of estrogen and progesterone receptors in the treatment of breast cancer

  1980cited by this paper

• Health-related quality of life in critically ill survivors: specific impact of cardiac arrest in non-shockable rhythm

  2021cites this paper
• Prognostic Factors of Survival among Women with Metastatic Breast Cancer and Impact of Primary or Secondary Nature of Disease on Survival: A French Population‐Based Study

  2017cites this paper
• Exploring patient experiences of neo-adjuvant chemotherapy for breast cancer.

  2016cites this paper
• Age-related socio-economic and geographic disparities in breast cancer stage at diagnosis: a population-based study.

  2015cites this paper
• In breast cancer, are treatments and survival the same whatever a patient's age? A population‐based study over the period 1998–2009

  2015cites this paper